Management of Treatment-Resistant Eczema

Immediate Next Steps

• The British Medical Journal recommends verifying that the patient is applying medication twice daily to affected areas, using adequate amounts, and continuing treatment long enough to see results 1
• The British Journal of Dermatology suggests ensuring the patient is avoiding all irritant and fragranced products, which can perpetuate inflammation despite steroid use 3

Optimize Current Topical Therapy

• The American Academy of Dermatology recommends switching to a higher-potency topical corticosteroid, such as betamethasone dipropionate or clobetasol propionate 0.05% ointment, for treatment-resistant eczema 1
• The British Medical Journal advises applying once to twice daily for 2-4 weeks to gain control of active inflammation 1
• The National Comprehensive Cancer Network recommends combining topical corticosteroids with aggressive emollient therapy, using fragrance-free, hypoallergenic moisturizers liberally at least once daily to the entire body 4

Add Adjunctive Measures

• The British Medical Journal suggests prescribing oral antihistamines, such as cetirizine, loratadine, or fexofenadine, for pruritus relief, particularly at bedtime for sedative properties 1
• The British Journal of Dermatology recommends using soap-free cleansers and barrier preparations to protect compromised skin 3

When to Consider Referral to Dermatology

• The British Medical Journal advises referring to a dermatologist if the patient fails to respond to optimized topical therapy within 4-6 weeks 1
• The British Medical Journal recommends referring patients who fail to improve with high-potency topical corticosteroids despite documented adherence 1

Critical Pitfalls to Avoid

• The British Medical Journal warns against prescribing long-term systemic corticosteroids, which should only be used for short courses in severe flares and are not appropriate for maintenance therapy in adolescents 1
• The National Comprehensive Cancer Network advises avoiding very potent topical steroids on the face, using low-potency hydrocortisone on facial skin to prevent atrophy and telangiectasia 4
• The British Medical Journal recommends not exceeding 100g per month of moderately potent topical steroids without dermatology supervision, and ensuring regular clinical review with no unsupervised repeat prescriptions 5